go-v.orgdoi

A Novel Competing Endogenous RNA Network Reveals Potential Mechanisms and Biomarkers of Chemoresistance in Lung Adenocarcinoma

Weisha Liu, Hanxiao Zhou, Yue Qi, Peng Wang, Shangwei Ning, Yue Huang, Liuying Wang, Lei Cao, Kang Li · Journal of Cancer · 2024

  • DOI 10.7150/jca.102148
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2024

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2024

Abstract

Platinum resistance is a common cause of chemotherapy failure in lung adenocarcinoma (LUAD).Competing endogenous RNAs (ceRNAs), which function by competitively binding to miRNAs, can influence drug response.However, the regulatory mechanisms of ceRNAs underlying chemoresistance in LUAD remain largely unknown.Here, we proposed an integrated pipeline combining limma algorithm, miRNA binding prediction algorithm, expression correlation model and experimental support to identify functional lncRNA-miRNA-mRNA competing triplets associated with resistance, which showed variable competing patterns between resistant and sensitive cells.We found that a minority of altered ceRNAs overlapped in multiple types of cisplatin-resistant LUAD cell lines and were involved in biological processes known to mediate cancer drug response.We identified them as core resistance factors, forming a novel lncRNA-mediated resistance-related ceRNA network, which indicated a potential mechanism.Single-cell analysis revealed that these resistance-related ceRNAs regulated the functional states of LUAD cells, and survival analysis showed that they contributed to the prognosis of LUAD patients.The lncRNA regulators H19 and MIR193BHG were found to correlate with cisplatin activity in LUAD cell lines, and dysregulation of their expression triggered disorders of cisplatin response-related functions through multiple ceRNA regulatory axes in this network, suggesting them as potential resistance biomarkers and therapeutic targets.In summary, the integrated pipeline and the resulting data serve as a valuable resource for understanding the ceRNA mechanisms of chemoresistance and improving chemotherapy response.

Open the resolved locator · 10.7150/jca.102148

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 21:48 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v16p0720.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.